From professional translators, enterprises, web pages and freely available translation repositories.
réponse eular (%)
eular response (%)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
eular, bonne/ modérée 2
eular good/ moderate
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
rémission acr/eular index, n (%)
acr/eular index remission, n (%)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
réponse eular (bonne/modérée)
eular response (good/moderate)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
semaine 24: rémission acr/eular booléenne,
week 24: acr/eular boolean remission, n (%)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
semaine 52: rémission acr/eular booléenne, n (%)
week 52: acr/eular boolean remission, n (%)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
variations par rapport aux valeurs initiales eular, bonne/modérée 2 haq facit-f3 1 2
change from baselinen= 201n= 298eular good/moderate haq2 3 facit-f 1
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
les mesures de résultats incluaient les réponses acr et eular, le das 28 et des composants de la réponse acr et des données radiographiques.
outcome measures included acr and eular responses, das 28 and components of acr response and radiographic data . safety data were also included.
Last Update: 2018-02-13
Usage Frequency: 1
Quality:
la proportion de patients obtenant une réponse eular bonne ou modérée a été significativement plus élevée sous rituximab que sous méthotrexate seul (tableau 12) .
a good to moderate eular response was achieved by significantly more rituximab treated patients compared to patients treated with methotrexate alone (table 12) .
Last Update: 2008-03-04
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
actualitÉs en matiÈre d'outils diagnostiques et de mÉthodes thÉrapeutiques neurochem : nouvelles données sur fibrillex(mc) de nouvelles analyses des résultats de l'étude clinique de phase ii/iii de neurochem (laval) sur fibrillex(mc), un produit candidat de recherche pour le traitement de l'amylose amyloide a (aa), ont été présentées à la réunion de la ligue européenne contre le rhumatisme (eular).
diagnostics and therapeutics update neurochem: new fibrillex(tm) data further analyses of the results of neurochem's (laval) phase ii/iii clinical study for fibrillex(tm), an investigational product candidate for the treatment of amyloid a (aa) amyloidosis, were presented at the european league against rheumatism (eular) meeting.
Last Update: 2015-05-14
Usage Frequency: 1
Quality: